Diaceutics (FRA:7DC) FCF Margin % : -9.41% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Diaceutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Diaceutics's Free Cash Flow for the six months ended in Dec. 2023 was €-1.50 Mil. Diaceutics's Revenue for the six months ended in Dec. 2023 was €15.99 Mil. Therefore, Diaceutics's FCF Margin % for the quarter that ended in Dec. 2023 was -9.41%.

As of today, Diaceutics's current FCF Yield % is -3.50%.

The historical rank and industry rank for Diaceutics's FCF Margin % or its related term are showing as below:

FRA:7DC' s FCF Margin % Range Over the Past 10 Years
Min: -47.58 Med: -17.42 Max: 16.97
Current: -14.97

During the past 8 years, the highest FCF Margin % of Diaceutics was 16.97%. The lowest was -47.58%. And the median was -17.42%.

FRA:7DC's FCF Margin % is ranked worse than
52.49% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -11.47 vs FRA:7DC: -14.97

Diaceutics FCF Margin % Historical Data

The historical data trend for Diaceutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diaceutics FCF Margin % Chart

Diaceutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-26.46

-47.58

-36.08

1.15

-14.95

Diaceutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial									-44.70	11.74	-5.50	-22.65	-9.41

Competitive Comparison of Diaceutics's FCF Margin %

For the Diagnostics & Research subindustry, Diaceutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diaceutics's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diaceutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Diaceutics's FCF Margin % falls into.

Diaceutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Diaceutics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-4.113	/	27.509
	=	-14.95 %

Diaceutics's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.504	/	15.989
	=	-9.41 %

Diaceutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Diaceutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Diaceutics (FRA:7DC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diaceutics PLC (FRA:7DC) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

DXRX:UK

Address

Kings Hall Health and Wellbeing Park, Dataworks, First Floor, Building Two, Antrim, Belfast, GBR, BT9 6GW

Website

https://www.diaceutics.com

Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides the pharma and biotech companies with an end-to-end commercialization solution for the launch of precision medicine, enabled by DXRX The Diagnostic Network. DXRX is the diagnostic commercialization platform designed specifically for precision medicine, integrating multiple pipelines of real-world, real-time diagnostic testing data from a network of labs. These solutions are helping the pharma companies commercialize their precision medicines, enhance their return on investment and ultimately improve patients' lives.

Diaceutics (FRA:7DC) Headlines

No Headlines